Publication | Open Access

Contribution of plasminogen activators and their inhibitors to the survival prognosis of patients with Dukes' stage B and C colorectal cancer

Chemoprevention StrategyPlasminogen ActivatorsMedicineSurvival PrognosisPharmacologyColorectal CancerPathologyC Colorectal CancerOncologyTumor MicroenvironmentCancer Research